Fujiki, A <br/><br/>
Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.  [electronic resource] 

 -  Cardiovascular drugs and therapy  May 1996 
 - 159-66 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0920-3206 
<br/><br/><label>Standard No.: </label>10.1007/BF00823594  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Arrhythmia Agents--adverse effects<br/>Disopyramide--administration & dosage<br/>Electrophysiology<br/>Female<br/>Heart Conduction System--drug effects<br/>Humans<br/>Imidazoles--administration & dosage<br/>Lidocaine--administration & dosage<br/>Male<br/>Middle Aged<br/>Procainamide--administration & dosage<br/>Tachycardia, Atrioventricular Nodal Reentry--prevention & control<br/>Wolff-Parkinson-White Syndrome--complications